Brief: Enorama Pharma Gets Objection To Swedish Patent
May 26 (Reuters) - Enorama Pharma AB ERMA.ST :
* SAID ON MONDAY HAS RECEIVED AN OBJECTION TO THE SWEDISH
PATENT
FOR NICOTINE CHEWING GUM FORMULATION
* SAYS FERTIN PHARMA MADE THE OBJECTION
* OBJECTION PROCESS NORMALLY LASTS 12-24 MONTHS
Source text for Eikon: urn:newsml:reuters.com:*:nWkr4kXmHT
Further company coverage: ERMA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Enorama Pharma AB
See all newsBrief: Enorama Pharma Signs Agreements For Nic-S Tobacco-Free White Snus
Brief: Enorama Pharma Gets FDA Statement In Ongoing US Court Proceedings
Brief: Enorama Pharma Q2 Operating Loss SEK 11.7 Mln
Brief: FDA Upholds Refuse-To-File Decision On Enorama Pharma's PMTA Applications
Brief: Enorama Pharma Names Amy Walker New Interim CEO